A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...

The continued evolution of SARS-CoV-2 variants that evade immunity highlights a need to develop vaccines that elicit variant-specific antibodies and neutralize emerging strains. However, immune ...

Find out about the COVID-19 vaccines, the benefits of COVID-19 vaccination and the possible side effects.

The race to tame Covid-19 has resulted in a wealth of research, new vaccines and promising treatments that hold out the ...

Alnylam Pharmaceuticals’ ALNY primary top-line driver is its newest drug, Amvuttra (vutrisiran), which is approved in the ...

In some of Asia’s Covid-19 hotspots, powerful and wealthier citizens are nabbing booster shots even as most people remain ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...

Strategic emphasis has shifted away from Novavax-led commercialization toward enabling partners with global scale, exemplified by Sanofi’s worldwide rights to market the COVID vaccine and Pfizer’s ...

The adult nurse at Dorset Healthcare University NHS Foundation Trust 'explicitly' told her patient that the Covid vaccines ...

The outlook for the EGFR inhibitor market continues to be highly promising, supported by the increasing adoption of precision medicine in oncology and the broader use of targeted therapies across ...

The analysis included 14,019 cases of the Delta variant – 166 of whom were hospitalised – between April 12 and June 4.